Q3 2022 Holdings
Filed 2022-11-08 | 66 holdings | $40.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Alkermes PLC(ALKS) | SHS | G01767105 | $13.2K | 593,000 | 0.0% |
| Incyte Corp(INCY) | COM | 45337C102 | $19.3K | 289,000 | 0.0% |
| Seagen Inc(SGENUSD) | COM | 81181C104 | $22.7K | 166,200 | 0.1% |
| Horizon Therapeutics | SHS | G4617B105 | $28.2K | 454,973 | 0.1% |
| Allogene Therapeutics(ALLO) | COM | 019770106 | $539.0K | 50,000 | 1.3% |
| Axsome Therapeutics(AXSM) | COM | 05464T104 | $625.0K | 14,000 | 1.5% |
| Biocryst Pharms.(BCRX) | COM | 09058V103 | $718.0K | 57,000 | 1.8% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $756.0K | 17,000 | 1.8% |
| Beam Therapeutics Inc(BEAM) | COM | 07373V105 | $1.1M | 23,500 | 2.7% |
| Beigene ADR(ONC) | Sponsored ADR | 07725L102 | $2.1M | 15,700 | 5.2% |
| Caribou Biosciences Inc(CRBU) | COM | 142038108 | $2.7M | 257,892 | 6.6% |
| Ascendis Pharma ADR(ASND) | Sponsored ADR | 04351P101 | $3.0M | 29,400 | 7.4% |
| Aurinia Pharmaceuticals Inc(AUPH) | COM | 05156V102 | $4.3M | 573,530 | 10.5% |
| Biomarin Pharm.(BMRN) | COM | 09061G101 | $5.0M | 58,656 | 12.1% |
| Alnylam Pharms.(ALNY) | COM | 02043Q107 | $7.6M | 38,000 | 18.6% |
| Biogen Inc(BIIB) | COM | 09062X103 | $12.1M | 45,500 | 29.7% |